NCT02280031View on ClinicalTrials.gov

Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Small for Gestational AgeInfant, Very Low Birth WeightFetal Growth RetardationPreeclampsiaPremature Birth
Interventions
DRUG

Acetylsalicylic Acid

Capsule containing Acetylsalicylic Acid 80mg pill with lactose

DRUG

Placebo

Capsule containing placebo pill with lactose

Trial Locations (2)

G1L 3L5

Hôpital St-François d'Assise-CHUQ, Québec

G1V 4G2

Centre Hospitalier Universitaire de Québec (CHU de Québec)/Pavillon CHUL, Québec

All Listed Sponsors
lead

CHU de Quebec-Universite Laval

OTHER

NCT02280031 - Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. | Biotech Hunter | Biotech Hunter